Dova Pharmaceuticals, Inc. — Form D

Dova Pharmaceuticals, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-23. The offering totals $40.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2016-09-23
• Form: D
• Accession: 0001685071-16-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $40.0M
• Amount sold: $10.0M
• Remaining: $30.0M
• Minimum investment: $2.5M
• Investors: 1
• Date of first sale: 2016-09-19
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-271207

Issuer

• Name: Dova Pharmaceuticals, Inc.
• CIK: 0001685071
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2016
• Address: 200 GARRETT STREET, CHARLOTTESVILLE, VA, 22902
• Phone: 434-980-8105

Officers, directors & promoters (17)

More

• CIK 1685071 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search